Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immuneering Corp | 74,530 | reported | 15 Jan 2026 | tx 7+151,468 |
| ChemoCentryx, Inc. | 0 | reported | 20 Oct 2022 | tx 280+6,081,706−9,425,717 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2026 | PURCHASE | Immuneering Corp | 21,645 | 4.67 USD | |
| 27 Jun 2025 | PURCHASE | Immuneering Corp | 9,500 | 3.66 USD | |
| 17 Jun 2025 | PURCHASE | Immuneering Corp | 40,485 | 2.21 USD | first after silence |
| 13 Jun 2025 | GRANT_AWARD | Immuneering Corp | 33,350 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Immuneering Corp | 8,588 | 0.00 USD | deriv |
| 22 Mar 2024 | PURCHASE | Immuneering Corp | 2,900 | 2.55 USD | |
| 11 Mar 2024 | GRANT_AWARD | Immuneering Corp | 35,000 | 0.00 USD | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 2,393,352 | — | |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 8,231 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 262,431 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 7,002 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 27,998 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 239,934 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 278,307 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 11,693 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 222,088 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 7,912 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 68,998 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 2,502 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 188,408 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 4,192 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 13,825 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 406,175 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 14,188 | — | deriv |
| 20 Oct 2022 | OTHER | ChemoCentryx, Inc. | 285,812 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 Jun 2025.